Friday, July 31, 2026

China and North Korea Mark 80th Victory Day, Pledging to Bolster ‘Blood Alliance’

The Chinese Embassy in North Korea celebrated the 80th Victory Day, emphasizing the strong ties between China and North Korea.

Park Sang-yong Under Investigation: Allegations of Coercion in North Korean Remittance Case

Prosecutor Park Sang-yong faces allegations of testimony manipulation in the Ssangbangwool case amid political tensions in South Korea.

Hanwha’s 2 Billion USD MRIV Contract: What to Expect from the Golden Defender

Philly Shipyard wins a $2 billion contract to build Missile Range Instrumentation Vessels for the U.S. Missile Defense Agency, enhancing defense capabilities.

News1

Author's Latest

KAIST Develops Advanced Quadrupedal Robot with Self-Adaptive Walking Skills for Outdoor Environments

KAIST's Professor Park Hae-won reveals a new control tech for quadrupedal robots, enabling versatile locomotion in diverse terrains.

Investing in the Future: A Deep Dive into ROBOTIS’s 70 Million USD Physical AI Factory in Uzbekistan

RoboTis is establishing a Physical AI Data Factory in Uzbekistan, combining robotics manufacturing with AI data collection and training.

Unlocking the Future: Diden Robotics and Movin’s Breakthrough in Humanoid AI Motion Capture

Diden Robotics and Movin collaborate to enhance humanoid robots with precise human motion data for improved industrial applications.

Samsung Galaxy Fold Unveiling: What to Expect from the Revolutionary Flex Titanium Display?

Samsung reveals 'Flex Titanium' display technology for its new foldable phone, set to launch on the 22nd.

Revolutionary Low-Dose 3-Drug Combo: The Future of Hypertension Treatment in 2026

A study shows a new combination pill for hypertension is safer and more effective than traditional treatments, improving patient adherence.

Tesla’s New FSD Subscription: Is the 150,000 KRW Monthly Fee Worth It?

Tesla introduces a monthly subscription for its Full Self-Driving feature, easing customer discontent after recent price hikes.

How KAIST’s AI Framework Enhances Safety While Personalizing ChatGPT-Like Models

KAIST's Professor Kim Chang-Ik develops a novel AI learning framework that enhances safety while customizing large language models.

HLB’s Liver Cancer Drug: FDA’s VAI Conclusion Sparks Hope for Approval

HLB's Rivoceranib facility passed FDA inspection, receiving VAI classification, moving towards new liver cancer drug approval.

How Salidroside from Korean Ginseng Can Combat Insulin Resistance and Prevent Diabetes

Research reveals salicin from tianma improves insulin resistance, aiding diabetes prevention and intestinal health restoration.

How LG’s 2026 GITC Empowers Disabled Youth with AI Skills for Future Careers

LG Electronics empowers youth with disabilities through AI skills at the 2026 GITC, enhancing their career prospects and social integration.

Penetrium’s Innovative Cancer Drug Enters Phase 2 Trials in the U.S.: What You Need to Know

Penetrium Bioscience is submitting an IND for Penetrium to start Phase 2 cancer trials in the U.S., leveraging prior safety data.

Smoking Raises Fatty Liver Risk by Up to 1.5 Times Among Young Adults

Young adult smokers face a higher risk of fatty liver disease, with significant findings on its impact regardless of obesity or alcohol consumption.

[Exclusive] HLB’s Liver Cancer Drug Clears Camrelizumab CMC Review, but Hengrui Manufacturing Facility Becomes New Hurdle

HLB's liver cancer drug approval faces delays due to FDA findings at Hengrui's facility, despite resolution of previous issues.

Hyundai Construction Joins Forces with FANCO: What to Expect from the EAGL-1 SMR Project?

Hyundai Engineering & Construction partners with FANCO for the U.S. EAGL-1 SMR project, covering design to construction phases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.